Wolf, Myles

FGF23 induces left ventricular hypertrophy

Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation

Parathyroid Disorders and TreatmentsCardiac Fibrosis and Remodeling

Cited by 2,027

Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: The Chronic Renal Insufficiency Cohort study

Scialla, J. J., Appel, L. J., Wolf, M., Yang, W., Zhang, X., Sozio, S. M., Miller, E. R., Bazzano, L. A., Cuevas, M., Glenn, M. J., et al. (2012) · Journal of Renal Nutrition

Parathyroid Disorders and TreatmentsRenal function and acid-base balance

Cited by 115

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

Ratziu, V., Harrison, S. A., Loustaud-Ratti, V., Bureau, C., Lawitz, E., Abdelmalek, M., Alkhouri, N., Francque, S., Girma, H., Darteil, R., et al. (2023) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 101

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease

Dussold, C., Gerber, C., White, S., Wang, X., Qi, L., Francis, C., Capella, M., Courbon, G., Wang, J., Li, C., et al. (2019) · Bone Research

Parathyroid Disorders and TreatmentsBone Metabolism and Diseases

Cited by 96